GlassScriptPhysician profile
David Glenn Whaley
NPI 1174630297
$6,342.68
in general payments reported to CMS, 2019-2025
47 companies · $818 in 2025
The $818 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $699 · 2021: $1,683 · 2022: $1,394 · 2023: $673 · 2024: $283 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,774.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $692.52 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $535.42 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $502.85 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $500.48 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $314.20 | 2020-2022 | |
| Exact Sciences Corporation | $296.58 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $270.37 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $203.54 | 2019-2022 | |
| Amarin Pharma, INC. | $199.86 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $191.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $176.95 | 2019-2025 | Verquvo |
| Axsome Therapeutics, INC. | $166.96 | 2024-2025 | Sunosi |
| Amgen INC. | $157.78 | 2019-2023 | Otezla, Repatha |
| Biohaven Pharmaceuticals, INC. | $149.13 | 2020-2021 | |
| Abbott Laboratories | $148.58 | 2021-2025 | Freestyle Libre 3 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Whaley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.